|
114
|
317
|
4fa3A |
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (r)-1-(naphthalen-2-ylsulfonyl)piperidine-3-carboxylic acid (86) |
|
110
|
282
|
4f40A |
X-ray crystal structure of apo prostaglandin f synthase from leishmania major friedlin |
|
121
|
315
|
4famA |
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)benzoic acid (17) |
|
115
|
318
|
4dz5A |
W227f active site mutant of akr1c3 |
|
115
|
315
|
4dbwA |
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (akr1c3) in complex with nadp+ and 2'-desmethyl-indomethacin |
|
114
|
315
|
4dbuA |
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (akr1c3) in complex with nadp+ and 3-((4 -(trifluoromethyl)phenyl)amino)benzoic acid |
|
120
|
315
|
4dbsA |
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (akr1c3) in complex with nadp+ and 3'-[(4-nitronaphthalen-1-yl)amino]benzoic acid |
|
119
|
337
|
4astA |
The apo structure of a bacterial aldo-keto reductase akr14a1 |
|
121
|
337
|
4aubA |
The complex structure of the bacterial aldo-keto reductase akr14a1 with nadp and citrate |
|
105
|
271
|
3wbxA |
Crystal structure of gox0644 at apoform |
|
101
|
271
|
3wbwA |
Crystal structure of gox0644 in complex with nadph |
|
103
|
299
|
3wg6A |
Crystal structure of conjugated polyketone reductase c1 from candida parapsilosis complexed with nadph |
|
111
|
307
|
3wczA |
Crystal structure of bombyx mori aldo-keto reductase (akr2e4) in complex with nadp |
|
81
|
271
|
3wbyA |
Crystal structure of gox0644 d53a mutant in complex with nadph |
|
106
|
304
|
3vxgA |
Crystal structure of conjugated polyketone reductase c2 from candida parapsilosis |
|
113
|
325
|
3uzxA |
Crystal structure of 5beta-reductase (akr1d1) e120h mutant in complex with nadp+ and epiandrosterone |
|
114
|
325
|
3uzyA |
Crystal structure of 5beta-reductase (akr1d1) e120h mutant in complex with nadp+ and 5beta-dihydrotestosterone |
|
98
|
337
|
3v0uA |
Crystal structure of perakine reductase, founder member of a novel akr subfamily with unique conformational changes during nadph binding |
|
113
|
325
|
3uzzA |
Crystal structure of 5beta-reductase (akr1d1) e120h mutant in complex with nadp+ and delta4-androstenedione |
|
115
|
325
|
3uzwA |
Crystal structure of 5beta-reductase (akr1d1) e120h mutant in complex with nadp+ |
|
103
|
336
|
3v0tA |
Crystal structure of perakine reductase, founder member of a novel akr subfamily with unique conformational changes during nadph binding |
|
105
|
316
|
3v36A |
Aldose reductase complexed with glceraldehyde |
|
89
|
336
|
3v0sA |
Crystal structure of perakine reductase, founder member of a novel akr subfamily with unique conformational changes during nadph binding |
|
109
|
316
|
3v35A |
Aldose reductase complexed with a nitro compound |
|
117
|
316
|
3ug8A |
Akr1c3 complex with indomethacin at ph 7.5 |
|
115
|
316
|
3uweA |
Akr1c3 complexed with 3-phenoxybenzoic acid |
|
116
|
314
|
3ugrA |
Akr1c3 complex with indomethacin at ph 6.8 |
|
115
|
316
|
3ufyA |
Akr1c3 complex with r-naproxen |
|
95
|
337
|
3uyiA |
Crystal structure of perakine reductase, founder member of a novel akr subfamily with unique conformational changes during nadph binding |
|
94
|
281
|
3up8A |
Crystal structure of a putative 2,5-diketo-d-gluconic acid reductase b |
|
103
|
315
|
3u2cA |
Aldose reductase in complex with nsaid-type inhibitor at 1.0 a resolution |
|
111
|
316
|
3t42A |
Human aldose reductase in complex with a nitrile-containing idd inhibitor |
|
108
|
316
|
3s3gA |
Crystal structure of human aldose reductase complexed with tolmetin |
|
107
|
318
|
3rx2A |
Crystal structure of human aldose reductase complexed with sulindac sulfone |
|
110
|
318
|
3rx3A |
Crystal structure of human aldose reductase complexed with sulindac |
|
107
|
318
|
3rx4A |
Crystal structure of human aldose reductase complexed with sulindac sulfide |
|
114
|
316
|
3r8hA |
Akr1c3 complex with zomepirac |
|
116
|
316
|
3r8gA |
Akr1c3 complex with ibuprofen |
|
118
|
316
|
3r94A |
Akr1c3 complex with flurbiprofen |
|
117
|
316
|
3r7mA |
Akr1c3 complex with sulindac |
|
106
|
315
|
2nvdA |
Human aldose reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2) |
|
122
|
326
|
5wieA |
Crystal structure of a kv1.2-2.1 chimera k+ channel v406w mutant in an inactivated state |
|
117
|
326
|
5uxfA |
Crystal structure of mouse recon (akr1c13) in complex with cyclic di-amp |
|
125
|
330
|
5t79A |
X-ray crystal structure of a novel aldo-keto reductases for the biocatalytic conversion of 3-hydroxybutanal to 1,3-butanediol |
|
104
|
316
|
5oukA |
Crystal structure of human akr1b1 complexed with nadp+ and compound 41 |
|
111
|
316
|
5ou0A |
Crystal structure of human akr1b1 complexed with nadp+ and compound 37 |
|
109
|
316
|
5oujA |
Crystal structure of human akr1b1 complexed with nadp+ and compound 39 |
|
91
|
316
|
5liuX |
Crystal structure of human akr1b10 complexed with nadp+ and the inhibitor idd388 |
|
93
|
316
|
5likX |
Crystal structure of human akr1b10 complexed with nadp+ and the inhibitor mk181 |
|
106
|
316
|
4ys1A |
Human aldose reductase complexed with a ligand with an idd structure (2) at 1.07 a. |
